|
Volumn 54, Issue 1, 2006, Pages 104-109
|
Comorbidity profile of dementia patients in primary care: Are they sicker?
|
Author keywords
Alzheimer's disease; Comorbidity; Dementia
|
Indexed keywords
ALPRAZOLAM;
AMFEBUTAMONE;
AMITRIPTYLINE;
AMOXAPINE;
BENZATROPINE;
BROMPHENIRAMINE;
CHLORPHENIRAMINE;
CHLORPROMAZINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
DESIPRAMINE;
DIPHENHYDRAMINE;
DOXEPIN;
HYDROXYZINE;
HYOSCYAMINE;
IMIPRAMINE;
IPRATROPIUM BROMIDE;
LOXAPINE;
MECLOZINE;
NORTRIPTYLINE;
OXYBUTYNIN;
PAROXETINE;
PERPHENAZINE;
PETHIDINE;
PROMAZINE;
PROMETHAZINE;
QUETIAPINE;
THIORIDAZINE;
TRIFLUOPERAZINE;
UNINDEXED DRUG;
AGE;
ALZHEIMER DISEASE;
ANTICHOLINERGIC EFFECT;
ARTICLE;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMORBIDITY;
DEMENTIA;
DISEASE SEVERITY;
FEMALE;
GENDER;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIMARY MEDICAL CARE;
PUBLIC HOSPITAL;
RACE;
URBAN POPULATION;
AGED;
AGED, 80 AND OVER;
CASE-CONTROL STUDIES;
CHOLINERGIC ANTAGONISTS;
CHRONIC DISEASE;
COMORBIDITY;
CROSS-SECTIONAL STUDIES;
DEMENTIA;
FEMALE;
HUMANS;
MALE;
POLYPHARMACY;
PRIMARY HEALTH CARE;
|
EID: 33645128411
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2005.00543.x Document Type: Article |
Times cited : (225)
|
References (35)
|